Last 24 quarters of trend data · Healthcare · Drug Manufacturers - Specialty & Generic
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Flora Growth Corp.'s quarterly P/E stands at 0.7x.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -5.55 | 0.74 | — | — | — | — | — | — | — | — | 135.45 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.49 | — | 0.24 | 0.21 | 0.10 | 3.43 | 5.45 | 2.89 | 11.14 | 6.54 | 4.99 | 7.27 | 19.71 |
| — | — | -95.5% | -92.7% | -99.1% | -47.6% | +9.2% | -60.3% | -43.5% | -60.3% | -90.8% | -85.7% | -92.7% | |
| P/B Ratio | 19.61 | 0.09 | 0.15 | 3.09 | 0.95 | 40.56 | 52.38 | 21.89 | 255.97 | 73.46 | 26.33 | 61.04 | 28.42 |
| — | -99.8% | -99.7% | -85.9% | -99.6% | -44.8% | +98.9% | -64.1% | +800.8% | +447.0% | -32.4% | +108.9% | -58.9% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | 169.76 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | 144.48 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Flora Growth Corp.'s operating margin was -10.8% in Q4 2025, up 22.7 pp QoQ and up 33.7 pp YoY. The trailing four-quarter average of -17.5% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 105.4% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.3% | -1.1% | 3.4% | 19.1% | 24.5% | 19.8% | 22.8% | 20.2% | 21.4% | 19.4% | 28.5% | 18.5% | 27.7% |
| — | -105.4% | -84.9% | -5.3% | +14.6% | +1.9% | -20.2% | +9.4% | -22.8% | -23.0% | -40.8% | -50.3% | -48.7% | |
| Operating Margin | -30.7% | -10.8% | -33.5% | -17.3% | -8.3% | -44.5% | -29.6% | -22.6% | -13.8% | -41.1% | -3.1% | -186.7% | -12.3% |
| — | +75.8% | -13.1% | +23.1% | +39.9% | -8.3% | -849.8% | +87.9% | -12.3% | +72.5% | +93.1% | +22.4% | +92.1% | |
| Net Margin | -30.5% | 503.4% | -68.3% | -16.3% | -6.4% | -46.0% | -30.3% | -16.8% | -18.7% | -56.2% | 7.1% | -206.4% | -20.1% |
| — | +1194.4% | -125.7% | +2.8% | +65.6% | +18.2% | -523.7% | +91.9% | +6.7% | +48.1% | +109.4% | +25.2% | +86.9% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -11.8% | -162.3% | -19.3% | -54.9% | -16.4% | -126.4% | -56.1% | -46.1% | -70.7% | -103.5% | 10.6% | -138.8% | -7.0% |
| — | -28.3% | +65.5% | -19.2% | +76.9% | -22.1% | -629.1% | +66.8% | -903.7% | -359.9% | +183.7% | -292.0% | +28.4% | |
| ROA | -5.7% | -107.6% | -13.8% | -10.7% | -3.1% | -22.1% | -12.7% | -9.7% | -14.1% | -36.6% | 4.0% | -82.4% | -4.9% |
| — | -387.3% | -8.4% | -10.6% | +77.9% | +39.7% | -419.0% | +88.3% | -187.2% | -126.6% | +141.1% | -164.0% | — | |
| ROIC | -5.5% | 2.0% | -7.5% | -20.6% | -12.4% | -92.0% | -39.5% | -42.8% | -35.9% | -64.4% | -3.5% | -93.7% | -3.4% |
| — | +102.2% | +81.0% | +51.9% | +65.4% | -42.9% | -1034.8% | +54.4% | -946.7% | -156.8% | +43.0% | -394.9% | +53.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Flora Growth Corp.'s Debt/EBITDA ratio is 22.9x — elevated, raising questions about debt serviceability.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.76 | 0.76 | 0.05 | 1.93 | 1.53 | 1.09 | 1.02 | 0.68 | 1.82 | 0.57 | 0.24 | 0.33 | 0.07 |
| — | -29.6% | -95.2% | +184.8% | -15.5% | +89.5% | +330.2% | +105.5% | +2370.1% | +759.6% | +287.2% | +456.1% | — | |
| Debt / EBITDA | — | 22.89 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.01 | 1.01 | 2.08 | 0.96 | 1.05 | 1.05 | 1.02 | 1.16 | 1.13 | 1.31 | 1.44 | 1.25 | 1.80 |
| — | -3.7% | +104.1% | -17.7% | -6.8% | -20.0% | -29.2% | -7.0% | -37.4% | -26.5% | -45.5% | -60.7% | — | |
| Quick Ratio | 0.79 | 0.79 | 1.79 | 0.61 | 0.67 | 0.74 | 0.64 | 0.79 | 0.65 | 0.79 | 0.80 | 0.76 | 1.13 |
| — | +6.4% | +179.2% | -23.5% | +3.3% | -5.9% | -19.4% | +4.4% | -42.8% | -38.5% | -44.8% | -63.5% | — | |
| Interest Coverage | -101.30 | 22.83 | -53.54 | — | -19.16 | -31.38 | -136.74 | — | -112.95 | -295.32 | -33.75 | -1430.75 | -103.04 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 24 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FLGC stock.
Flora Growth Corp.'s current P/E is -5.5x. The average P/E over the last 1 quarters is 0.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Flora Growth Corp.'s current operating margin is -30.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Flora Growth Corp.'s business trajectory between earnings reports.